Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warfarin versus Xarelban in atrial fibrillation
IRCT20170530034232N2Phase 4Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Atrial fibrillation (AFib) comparing Warfarin group with Rivaroxaban group (2 arms). Primary endpoint: Bleeding. Started Oct 2019; status: completed.
02
Drugs
warfarinrivaroxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT20170530034232N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170530034232N2.